Understanding the charismatic potential of nanotechnology to treat skin carcinoma.
Aamravi SatheBhupendra G PrajapatiSankha BhattacharyaPublished in: Medical oncology (Northwood, London, England) (2023)
Carcinoma is a condition that continues to pose a significant challenge, despite current medical advances. Skin carcinoma is the leading cause of cancer, and it has seen a massive increase all over the world. The challenges with current treatment are due to toxicity that leads to many more skin complications. Due to this to avoid such complications by designing diverse nanoparticles as delivery carriers, nanomedicine is employed as a hub for diagnostics and therapy. Liposomes, gold nanoparticles, transferases, nanofibers, etc., can all be used as delivery nanocarriers. These nanoparticles' structures and characteristics protect the medicine from degradation and improve its stability. Surface modifying agents and procedures are employed to functionalize nanoparticles, resulting in smart delivery systems. The application of nanotechnology-based approaches systematically increases drug delivery to target cells. Skin cancer has several challenges, including a long time to diagnose early types of cancer and a slower growth rate. This review focuses on innovative skin cancer therapy techniques, focusing on nanotechnology and the challenges associated with current treatment of skin cancer.
Keyphrases
- drug delivery
- cancer therapy
- skin cancer
- gold nanoparticles
- soft tissue
- papillary thyroid
- wound healing
- drug release
- squamous cell
- risk factors
- squamous cell carcinoma
- cell death
- high resolution
- mesenchymal stem cells
- stem cells
- replacement therapy
- bone marrow
- cell cycle arrest
- mass spectrometry
- reduced graphene oxide
- smoking cessation